Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology

Mh Buch*, L Silva Fernandez, L Carmona, D Aletaha, R Christensen, B Combe, P Emery, Gianfranco Ferraccioli, F Guillemin, Tk Kvien, R Landewe, K Pavelka, K Saag, Js Smolen, D Symmons, D Van Der Heijde, J Welling, G Wells, R Westhovens, A ZinkM. Boers

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

22 Citazioni (SciVal)

Abstract

Our initiative aimed to produce recommendations on post-randomised controlled trial (RCT) trial extension studies (TES) reporting using European League Against Rheumatism (EULAR) standard operating procedures in order to achieve more meaningful output and standardisation of reports.
Lingua originaleInglese
pagine (da-a)963-969
Numero di pagine7
RivistaAnnals of the Rheumatic Diseases
Volume74
Numero di pubblicazione6
DOI
Stato di pubblicazionePubblicato - 2015
Pubblicato esternamente

All Science Journal Classification (ASJC) codes

  • Reumatologia
  • Immunologia e Allergia
  • Immunologia
  • Biochimica, Genetica, Biologia Molecolare Generali

Keywords

  • Advisory Committees
  • DMARDs (biologic)
  • Delphi Technique
  • Epidemiology
  • Randomized Controlled Trials as Topic
  • Research Design
  • Research Report
  • Rheumatoid Arthritis
  • Rheumatology

Fingerprint

Entra nei temi di ricerca di 'Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology'. Insieme formano una fingerprint unica.

Cita questo